These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23351306)

  • 21. Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells.
    Burton P; Adams DR; Abraham A; Allcock RW; Jiang Z; McCahill A; Gilmour J; McAbney J; Kaupisch A; Kane NM; Baillie GS; Baker AH; Milligan G; Houslay MD; Mountford JC
    Biochem J; 2010 Dec; 432(3):575-84. PubMed ID: 20923411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the chiral isomers of erythro- and threo-9-(2-hydroxy-3-nonyl)adenine on purine metabolism in sarcoma 180 cells.
    Chen SF; Stoeckler JD; Choi HS; Burgess FW; Marcaccio EJ; Steen PA; Berman SF; Parks RE; Panzica RP; Abushanab E
    Biochem Pharmacol; 1982 Dec; 31(24):3955-60. PubMed ID: 7159473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.
    Carson DA; Seegmiller JE
    J Clin Invest; 1976 Feb; 57(2):274-82. PubMed ID: 176177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison and possible homology of isozymes of adenosine deaminase in Aves and humans.
    Ratech H; Thorbecke GJ; Meredith G; Hirschhorn R
    Enzyme; 1981; 26(2):74-84. PubMed ID: 7238474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine deaminase inhibitors: synthesis and biological evaluation of unsaturated, aromatic, and oxo derivatives of (+)-erythro-9-(2'S-hydroxy-3'R-nonyl)adenine [(+)-EHNA].
    Pragnacharyulu PV; Varkhedkar V; Curtis MA; Chang IF; Abushanab E
    J Med Chem; 2000 Nov; 43(24):4694-700. PubMed ID: 11101360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles.
    Cristalli G; Eleuteri A; Volpini R; Vittori S; Camaioni E; Lupidi G
    J Med Chem; 1994 Jan; 37(1):201-5. PubMed ID: 8289197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
    Singhal D; Ho NF; Anderson BD
    J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine.
    Duncan GS; Wolberg G; Schmitges CJ; Deeprose RD; Zimmerman TP
    J Immunopharmacol; 1982; 4(1-2):79-100. PubMed ID: 6296234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals.
    Correia-de-Sá P; Ribeiro JA
    Neuroscience; 1996 Jul; 73(1):85-92. PubMed ID: 8783232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine deaminase inhibitors. Synthesis and biological evaluation of C1' and nor-C1' derivatives of (+)-erythro-9-(2(S)-hydroxy-3(R)-nonyl)adenine.
    Harriman GC; Poirot AF; Abushanab E; Midgett RM; Stoeckler JD
    J Med Chem; 1992 Oct; 35(22):4180-4. PubMed ID: 1433220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational change of adenosine deaminase during ligand-exchange in a crystal.
    Kinoshita T; Tada T; Nakanishi I
    Biochem Biophys Res Commun; 2008 Aug; 373(1):53-7. PubMed ID: 18549808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine.
    Podzuweit T; Nennstiel P; Müller A
    Cell Signal; 1995 Sep; 7(7):733-8. PubMed ID: 8519602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated enzymatic measurement of adenosine deaminase isoenzyme activities in serum.
    Muraoka T; Katsuramaki T; Shiraishi H; Yokoyama MM
    Anal Biochem; 1990 Jun; 187(2):268-72. PubMed ID: 2382828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graphene oxide based fluorescent aptasensor for adenosine deaminase detection using adenosine as the substrate.
    Xing XJ; Liu XG; Yue-He ; Luo QY; Tang HW; Pang DW
    Biosens Bioelectron; 2012; 37(1):61-7. PubMed ID: 22613226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rat brain adenosine deaminase after 2'-deoxycoformycin administration: biochemical properties and evidence for reduced enzyme levels detected by 2'-[3H]deoxycoformycin ligand binding.
    Padua RA; Geiger JD; Delaney SM; Nagy JI
    J Neurochem; 1992 Feb; 58(2):421-9. PubMed ID: 1729390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
    Barton RW
    Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of adenosine deaminase inhibition on blood pressure in old spontaneously hypertensive rats.
    Tofovic SP; Kusaka H; Li P; Jackson EK
    Clin Exp Hypertens; 1998 Apr; 20(3):329-44. PubMed ID: 9605386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-toxicity immunosuppression by specific inhibition of adenosine deaminase (ADA): prolongation of mouse skin grafts with erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
    Lum CT; Sutherland DE; Foker JE; Najarian JS
    Surg Forum; 1977; 28():320-2. PubMed ID: 364724
    [No Abstract]   [Full Text] [Related]  

  • 39. Endogenous adenosine modulation of 22Na uptake by rat brain synaptosomes.
    Ribeiro JA; Lobo MG; Sebastião AM
    Neurochem Res; 2003 Oct; 28(10):1591-5. PubMed ID: 14570405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postischemic cardiac function recovery in the isolated rat heart: effects of adenosine deaminase and nucleoside transport inhibition.
    Keeling IM; Obermayr RP; Schneider B; Spieckermann PG
    Langenbecks Arch Surg; 2000 Dec; 385(8):531-7. PubMed ID: 11201010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.